Biomaterials for medical implantation -Research strategies- Pubrica
                     BIOMATERIALS FOR  
MEDICAL  
IMPLANTATION-  
RESEARCH 
STRATEGIES
An Academic presentation by
Dr. Nancy Agnes, Head, Technical Operations, 
Pubrica  Group: www.pubrica.com
Email: [email protected]
Today's 
Discussion
Outlin
Introduction
e
Emergence of Biomaterials
Antimicrobial Strategy External Clinical Translation: 
Main  Collaborators and Players
Issues with the Partners and 
Players  Future Research on 
Biomaterials
Introductio
n
Biomaterials and medical instruments are  
widely researched and incorporated, which  
greatly increase the quality of human life, 
 thanks to the rapid advancement of  
biomedical science and practice.
The market for biomaterials and medical  
devices has risen dramatically as the world's 
 population ages.
Contd...
With the introduction of novel implant  
materials, including drug-carrying stents for  
regenerative medicine, joint repair materials,
prostheses, and embedded detection
sensors, the global biomaterial market is
expanding exponentially.
It is probable to advance at a CAGR of 13.7  
percent over 2021, reaching a net worth of
$130 billion.
This article discusses biomedical advances  
and innovations that help researchers to find 
 the research gaps.
Emergence 
Polymers are used in facial prostheses,
of  tracheal tubing, kidney and liver sections, heart 
Biomaterial  components, and other biomedical  
instruments.
s
The ultrahigh molecular weight polyethene  
(UHMWPE) is used in the knee, hip, and  
shoulder joints.
The polymers used in healthcare are  
mentioned in Table 1.
Contd...
Contd.
..
Various artificial implants to replace damaged tissues have been created in
recent  decades, and various implantable biosensors have been used to:
1. Maintain functional physiology by monitoring the human body, including weakened 
 and malfunctioning tissues that artificial substitutes can replace, such as vitreous  
bodies and joints,
2. Orthopedic implants that facilitate osseointegration and fracture healing
3. Pacemakers are electronic devices that help to regulate irregular heart rhythms, 
 stents used to treat arterial stenosis
Contd...
4. Nerve probes are used to treat and control the electroencephalogram of patients with 
 brain disorders and
5. Patients with chronic diabetes may use continuous blood glucose monitors to track 
 their blood glucose levels in real-time.
Contd...

Antimicrobial  
Rapid biomaterial production is fraught with risk. Strategy 
External  
Most sensors and implants are recognised as  
"alien substances" by the host. Clinical  
Translation: 
The immune system activates dynamic signal  
cascades during wound-healing procedures,  Main  
resulting in fibrosis collagen encapsulation on  
the implanted materials and instruments  Collaborators 
followed by complications. and  Players
Contd...
This process is known as the foreign-body response or foreign-body reaction (FBR), 
 the host body's natural protective mechanism.
Still, it largely affects the function of implanted materials.
The foreign-body response, also known as the foreign-body reaction (FBR), is
the  host body's normal defence mechanism.
Yet, it has a vast outcome on how embedded materials work.
Contd...
Contd...
The core collaborators and players in the backend translation of new, enhanced  
antimicrobial techniques treating biomaterial-associated infections (BAI) through a 
 wide range of applications and patient conditions collaborate in a dynamic 
relationship  that periodically results in new, licenced drugs.
The so-called "family of Ps," which includes patentors (academic and business  
researchers), manufacturers, payers, patients and clinicians, healthcare suppliers, 
 and policymakers, collaborate with regulatory authorities and legal bodies to decide  
the emerging innovations that arise and remain clinically adopted.
In this respect, these bodies' interactive functions in restricting and generating medical 
 device advances are summarised in Fig. 6.
Issues with  
the 
In a perfect future, biomaterial implant and system 
Partners   inventions, as well as breakthrough
and Players timecphrnoivqeumese,n twill be patented before publishing,  
allowing industry incentives to convert these ideas  
into goods with appropriate rights, exclusivities,  
and benefit motives.
Preclinical  and results from novel  
commercial cldineivciacles are submitted to  
 regulatory  first  for direct advice,
allowing marakuetthinogri taiensd pcaletiaern,t use clearance.
Contd...
However, 21st-century practises tending to be  
new since they are subject to significant and  
distinct stresses from various outlets, many of  
which complicate accurate, dependable, and  
timely technological advancement for the benefit  
of patients.
One of the factors influencing is:
There is a lot of to print academic
demand  findingsquickly there aren't many
ibnecceanutisve s to patent until they're published.
Contd...
However, for BAI victims, inventions released  
before successful patent protection are useless.
Without certain intellectual property rights and  
related necessary assurances for return-on-  
investment to push this translational phase, the  
industry would be reluctant to gamble new  
strategies into growth and future production.
Future  
The interesting developments on the horizon Research on 
for  biomaterials are listed below:
 
Immunomodulation is the process of adjusting the  Biomaterials
immune response to a certain degree.
Type 1 diabetes is an infectious disease in which  
the body's immune system attacks the pancreas'  
insulin-producing cells.
Immunomodulating biomaterials could help cure  
this illness.
Contd...
Researchers recently created an injectable synthetic biomaterial that reversed type
1 diabetes in non-obese diabetic mice, paving the way to create better
a  biodegradable platform to monitor the disease's impact.
Injectable biomaterials produce biomedical agents such as medicine,
genetic  materials, and proteins in greater numbers.
They allow for targeted transmission while preventing immune system absorption, 
 allowing for the treatment of various conditions.
Injectable biomaterials from engineered and naturally derived materials are being 
 studied to treat bone defects, tumours, and heart attacks.
Contd...
Orthopaedic implant technology has come a long way in only a few decades, and we 
 now have implants that perform well in a wide range of patients over long periods.
However, the new generation of implants is not without flaws, and long-term success  
remains a concern, particularly in younger, high-demand patients.
Hopefully, further advancements in implant technology research would lead to  
translational clinical applications for better implants.
Antimicrobial strategy implementation for biomaterial implants and devices would be  
more efficient and impactful if the relationships and alignment of overall translational  
techniques, procedures, and rules of engagement between the various main  
collaborators and participants are improved.
Contd...
This would more effectively deliver technological advances to patients and clinicians  
where they are desperately required.
The existing "free form" method for medical product invention, which reacts erratically 
 to various myopic inputs and goals from several different individual partners and  
players and lacks a robust inventory and alignment of priorities, is neither effective 
 nor productive in resolving these pressing clinical needs to minimise BAI.
Contact Us
UNITED KINGDOM
+44- 7424810299
INDIA
+91-9884350006
EMAIL
[email protected]